ASHLEY MENDOZA: Open Payments
NPI 1922561083 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 69 payments from 18 companies in 2025. Trend: 2023 $1,813 · 2024 $1,334 · 2025 $1,512
Food & beverage: $1,478Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $189 |
| AstraZeneca Pharmaceuticals LP | 8 | $179 |
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $148 |
| Grifols USA, LLC | 8 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $106 |
| REVANCE THERAPEUTICS, INC. | 3 | $105 |
| Amgen Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $68 |
Products named: DUPIXENT, AYVAKIT, NEFFY, Xembify, CUVITRU, DAXXIFY, Rhapsido, FASENRA.
Industry payments across TX — which companies pay providers there.
